Exploration of Pharmaceutical Practice for Drug-induced Liver Injury
- VernacularTitle:药物性肝损伤药学实践探索
- Author:
Lei KANG
1
;
Xiaowei LIN
;
Guodong WANG
;
Yufei XI
;
Jing TANG
;
Gaolin LIU
;
Guorong FAN
Author Information
1. 上海交通大学附属第一人民医院 上海201620
- Keywords:
Clinical pharmacist;
Drug-induced liver injury;
Pharmaceutical practice;
Atorvastatin;
Edaravone
- From:
China Pharmacist
2017;20(11):2025-2029
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore a new way of pharmaceutical service mode for disease treatment. Methods:Clinical pharmacists actively participated in the pharmaceutical care for a patient with mixed liver injury, and provided clinical pharmaceutical services through the adverse reaction analysis,etiological mechanisms exploration,therapeutic drugs selection and risk factors prevention. Re-sults:Clinical pharmacists cooperating closely with physicians helped to identify problems in time,and then the medication analysis in the fields of drug selection, dose determination, efficacy evaluation and indicators detection was performed, so that the strategies on medicine treatment could be adjusted timely as the disease progressed. With the gradual recovery of liver function, the patient dis-charged after the conditions were improved. Conclusion:By participating in pharmaceutical practice,clinical pharmacists can provide clinical pharmaceutical service,which is helpful to safety improvement and efficiency of drug administration. It is also an effective way to enhance the learning ability of pharmacists,and cultivate their clinical thinking and practice capacity.
